IPSC vs OCGN: stock comparison and AI forecast
Century Therapeutics, Inc. (IPSC) and Ocugen, Inc. (OCGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IPSC Century Therapeutics, Inc.
- Price
- $1.68 -27.3% · 6M
- Market Cap
- $304M
- P/E Ratio
- 24.0x
- Size
- small-cap
- AI Forecast
OCGN Ocugen, Inc.
- Market Cap
- $314M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IPSC and OCGN have similar market capitalizations ($304M and $314M).
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IPSC | OCGN |
|---|---|---|
| Market Cap | $304M | $314M |
| P/E Ratio | 24.00x | – |
| P/B Ratio | 1.31x | – |
| EPS | $0.07 | – |
| Book Value/Share | $1.28 | – |
| Revenue/Share | – | $0.01 |
| FCF/Share | $-0.49 | $-0.19 |
Profitability & Margins
| Metric | IPSC | OCGN |
|---|---|---|
| ROA | – | -60.5% |
| ROIC | -43.0% | – |
| Operating Margin | 53.6% | -1444.1% |
| Net Margin | – | -1367.3% |
| EBT Margin | 41.3% | -1547.3% |
| Tax Rate | -1.9% | – |
Financial Health
| Metric | IPSC | OCGN |
|---|---|---|
| Current Ratio | 8.28x | 0.77x |
| D/E Ratio | 0.24x | – |
| Financial Leverage | 1.24x | – |
| Interest Coverage | -257.9x | -13.8x |
| Working Capital | $110M | -$27M |
Cash Flow
| Metric | IPSC | OCGN |
|---|---|---|
| Operating Cash Flow | -$87M | -$64M |
| Free Cash Flow | -$88M | -$64M |
| Capital Spending | -$1M | -$210K |
| FCF/Sales | – | -1336.9% |
| CapEx/Sales | – | 4.4% |
Operational Efficiency
| Metric | IPSC | OCGN |
|---|---|---|
| Asset Turnover | – | 0.04x |
| Fixed Assets Turnover | – | 0.4x |
Income Statement
| Metric | IPSC | OCGN |
|---|---|---|
| Total Revenue | – | $5M |
| Operating Income | -$117M | -$69M |
| Net Income | – | -$65M |
| R&D Expense | $79M | $45M |
Dividend & Shareholder Information
| Metric | IPSC | OCGN |
|---|---|---|
| Shares Outstanding | 181M | 339M |
IPSC vs OCGN: stock comparison and AI forecast
Which is bigger, IPSC or OCGN?
IPSC and OCGN have similar market capitalizations ($304M and $314M).
Which one does Intratio's AI model rank higher, IPSC or OCGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.